The Therapeutic Goods Administration (TGA) is part of the Government Dept of Health and Ageing and regulates complementary medicines (CM's), including managing the listing of these on the Australian Register of Therapeutic Goods (ARTG). The TGA is seeking to improve the integrity of the certifications process for listing CM's on the ARTG by finalising the permitted (coded) indications that can be used, in order to limit the use of inappropriate claims and indications. Feedback was sought from the industry on the proposed changes to the method in which indications are included on the ARTG. They posed some general questions relating to the proposed changes and also sought industry specific information on the key issues of the consultation with regards to whether or not the proposed changes were supported.
